262938 Evidence-based heart disease and stroke prevention policy: Development of a tool to assess evidence quality

Tuesday, October 30, 2012 : 4:50 PM - 5:10 PM

Colleen Barbero, MPPA , Center for Public Health Systems Science, Washington University in St. Louis, St. Louis, MO
Michael Schooley, MPH , Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, GA
Siobhan Gilchrist, JD, MPH , Division for Heart Disease and Stroke Prevention, US Centers for Disease Control and Prevention, Atlanta, GA
Douglas A. Luke, PhD , Center for Tobacco Policy Research, Washington University in St. Louis, Saint Louis, MO
Amy A. Eyler, PhD , Prevention Research Center, Washington University in St. Louis, St. Louis, MO
The right evidence can assist policymakers in making better decisions to help prevent chronic disease. Evidence-based policy requires high quality evidence which can accurately predict the health outcomes and other consequences of existing policies and of policy initiatives. The Centers for Disease Control and Prevention Division for Heart Disease and Stroke Prevention (CDC DHDSP) is developing a policy rating system to assess the extent to which states enact evidence-based laws that address chronic disease prevention. The rating system will include application of an evidence hierarchy to assess the quality of the evidentiary support for various heart disease and stroke prevention policy strategies. This presentation will summarize the literature on evidence hierarchies for policymaking, describe the development of CDC DHDSP's Quality of the Supporting Evidence Assessment Tool, and discuss a process that can be used to identify policy evidence. It will also report the results of a pilot assessment of two heart disease and stroke prevention policy strategies: 1) blood pressure screening in community settings and 2) the use of accountable care organizations for chronic disease management. Finally, this presentation will outline plans for dissemination of the tool to policymakers and the public health community who are interested in assessing heart disease and stroke prevention policies and policy initiatives.

Learning Areas:
Chronic disease management and prevention
Public health or related public policy
Public health or related research

Learning Objectives:
1. Explain the development of evidence hierarchies for policymaking. 2. Identify evidence to support policy. 3. Assess evidence quality using CDC DHDSP’s Quality of the Supporting Evidence Assessment Tool.

Keywords: Policy/Policy Development, Chronic (CVD)

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a Statistical Data Analyst II at the Center for Tobacco Policy Research (CTPR) at Washington University in St. Louis. I have a Masters of Public Policy Administration and am pursuing my doctoral degree in public policy analysis. Previously, I served as a Data Manager on the Communities Putting Prevention to Work evaluation at CTPR. My expertise includes researching environmental, community development, and public health issues from a policy perspective.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.